Last reviewed · How we verify

Ketoprofen Oral Product

Aziende Chimiche Riunite Angelini Francesco S.p.A · Phase 1 active Small molecule

Ketoprofen Oral Product is a Small molecule drug developed by Aziende Chimiche Riunite Angelini Francesco S.p.A. It is currently in Phase 1 development. Also known as: OKI 80 mg.

At a glance

Generic nameKetoprofen Oral Product
Also known asOKI 80 mg
SponsorAziende Chimiche Riunite Angelini Francesco S.p.A
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ketoprofen Oral Product

What is Ketoprofen Oral Product?

Ketoprofen Oral Product is a Small molecule drug developed by Aziende Chimiche Riunite Angelini Francesco S.p.A.

Who makes Ketoprofen Oral Product?

Ketoprofen Oral Product is developed by Aziende Chimiche Riunite Angelini Francesco S.p.A (see full Aziende Chimiche Riunite Angelini Francesco S.p.A pipeline at /company/aziende-chimiche-riunite-angelini-francesco-s-p-a).

Is Ketoprofen Oral Product also known as anything else?

Ketoprofen Oral Product is also known as OKI 80 mg.

What development phase is Ketoprofen Oral Product in?

Ketoprofen Oral Product is in Phase 1.

Related